Kent and Canterbury Hospital
Canterbury, England, United Kingdom
Hospital in Canterbury, England
Ethelbert Rd, Canterbury CT1 3NG
About Kent and Canterbury Hospital
The Kent and Canterbury Hospital, colloquially known among residents as the K+C, is a community hospital in Canterbury, Kent, England. It is managed by the East Kent Hospitals University NHS Foundation Trust.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Kent and Canterbury Hospital
During the past decade, Kent and Canterbury Hospital conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 15 clinical trials were completed, i.e. on
average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 10 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
1999-12-01
2022-05-20
Completed
636
S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
1999-10-15
2018-05-01
Completed
983
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
2006-02-17
2019-02-11
Terminated
355
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
2008-08-08
Active, not recruiting
403
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer
2008-05-15
Active, not recruiting
394
Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
2008-04-01
Active, not recruiting
525
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kent and Canterbury Hospital" #1 sponsor was "University College, London" with 8 trials, followed by "Celgene" with 5 trials
sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "East Kent Hospitals University NHS Foundation Trust" with 4 trials sponsored and "Janssen Research & Development, LLC"
with 4 trials sponsored. Other sponsors include 53 different institutions and
companies that sponsored additional 47 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kent and Canterbury Hospital"
#1 collaborator was "Cancer Research UK" with 6 trials as a collaborator, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Cancer Trials Ireland" with 3 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 55 different institutions and companies that were
collaborators in the rest 56 trials.
Clinical Trials Conditions at Kent and Canterbury Hospital
According to Clinical.Site data, the most researched conditions in "Kent and Canterbury Hospital" are
"Multiple Myeloma" (10 trials), "Lymphoma" (8 trials), "Prostate Cancer" (7 trials), "Breast Cancer" (6 trials) and "Leukemia" (4 trials). Many other conditions were trialed in "Kent and Canterbury Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Kent and Canterbury Hospital
Most popular intervention types in "Kent and Canterbury Hospital" are "Drug" (64 trials), "Other" (13 trials), "Biological" (11 trials), "Procedure" (10 trials) and "Radiation" (9 trials). Other intervention types were less common.
The name of intervention was led by "Dexamethasone" (7 trials), "Placebo" (7 trials), "Bortezomib" (6 trials), "cyclophosphamide" (6 trials) and "Rituximab" (5 trials). Other intervention names were less common.
Clinical Trials Genders at Kent and Canterbury Hospital
The vast majority of trials in "Kent and Canterbury Hospital" are
72 trials for "All" genders, 10 trials for "Male" genders and 2 trials for "Female" genders.
Clinical Trials Status at Kent and Canterbury Hospital
Currently, there are NaN active trials in "Kent and Canterbury Hospital".
undefined are not yet recruiting,
13 are recruiting,
12 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 40 completed trials in Kent and Canterbury Hospital,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Kent and Canterbury Hospital, 1 "Phase 1"
clinical trials were conducted, 16 "Phase 2" clinical
trials and 53 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 7 trials that are defined as “Not Applicable".